Adiponectin; A Friend or Foe in Type 2 Diabetes Mellitus? A Review

The epidemic spread of diabetes is a modern-day health crisis.Treating and preventing diabetes has been identified as a major public health issue across the world.Type 2 Diabetes Mellitus (T2DM) is the most prevalent forms of the diabetes, and it is caused by a combination of environmental, behavioural, and genetic risk factors.There is a threefold increased risk of type 2 diabetes in those with a family history of diabetes mellitus compared to the unrelated individuals.The Adiponectin (AdipoQ) gene is only one of several genes that have a role in the progression of diabetes.Adiponectin a 30kDa protein hormone derived from an adipocyte, is encoded by the AdipoQ gene carrying a susceptibility locus for type 2 diabetes mellitus located on chromosome 3q27 which regulates adiponectin the most plentiful Adipokine in human plasma.The adiponectin has anti-inflammatory, antiatherogenic and insulin-sensitising properties that plays a censorious role in the progression of insulin resistance and type 2 diabetes mellitus.Plasma and serum levels of adiponectin (AdipoQ) are inversely correlated with type 2 diabetes mellitus.Single nucleotide polymorphism (SNPs) of the AdipoQ gene have been strongly associated with the pathogenicity of type 2 diabetes mellitus.However, there is still some debate about the findings, and there are clear racial and geographical differences.Reviewing what is known about Adiponectin and the Adiponectin (AdipoQ) Gene, with a focus on its function in the physiology and pathophysiology of type 2 diabetes mellitus, is the goal of this article.Adiponectin was found to play a significant pathological role in the progression of type 2 diabetes mellitus.